Timing And Typology of ConducTIon disturbanCes During TAVI

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

490 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The TACTIC-TAVI registry aims to collect information about a consecutive cohort of patients undergoing transcatheter aortic valve insertion. The registry is international, multi-centre and observational. The registry is planned to continue until the calculated sample size is achieved.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transcatheter AortiC Valve Implantation in AorTic StenosIs CardiogenIc Shock

NCT06638268

Aortic Stenosis Cardiogenic Shock

NOT_YET_RECRUITING NA

Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis

NCT05326126

Severe Symptomatic Aortic Stenosis

COMPLETED NA

Observational Study Relating to the Long-term Follow-up of Patients with Severe Aortic Stenosis Evaluated for Percutaneous Aortic Valve Replacement (TAVI).

NCT06679517

Severe Aortic Stenosis TAVI(Transcatheter Aortic Valve Implantation)

ENROLLING_BY_INVITATION

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation

NCT05758909

Aortic Valve Stenosis Heart Valve Diseases Aortic Valve Disease

ACTIVE_NOT_RECRUITING

CoreValve™ Evolut R™ 34 mm System Registry (CoreValve34)

NCT03621709

Aortic Valve Stenosis Transcatheter Aortic Valve Implantation

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients since February 2023 treated successfully with TAVI until the study endpoint will be deemed suitable for inclusion in the registry. The registry will:

1. collect the baseline clinical features of the study population.
2. evaluate the electrocardiogram (ECG) and contrast tomography (CT) scan parameters.
3. collect procedural characteristics including type and timing of any conduction disturbance
4. collect follow-up data including post-procedural ECG, echocardiographic and clinical outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Stenosis, Severe

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients successfully undergoing transcatheter aortic valve implantation for native severe aortic stenosis.

\-

Exclusion Criteria

1. Presence of previously implanted permanent cardiac pacemaker.
2. Valve-in-valve procedures.
3. No pre-procedural electrocardiogram is available.
4. No pre-procedural contrast CT TAVI is available.
5. Enrollment in another clinical trial.
6. Patients aged less than 18 years old.
7. Patients who do not consent for their data to be included in the registry.
8. Failed transcatheter aortic valve deployment. -

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No